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Introduction
Chronic kidney disease (CKD) is a progressive kidney 
dysfunction due to irreversible decreased renal function 
impairment. Dialysis and kidney transplantation are 
available options to prevent life-threatening uremia 
(1,2). The worldwide prevalence of chronic renal failure 
is 242 per million subjects and annually eight percent 
are added to this rate (3). The reported prevalence and 
incidence rates of CKD in Iran are 357 and 57 per million, 
respectively (4). The most common used management 
method is hemodialysis with a worldwide increasing rate 
(5,6). Regarding low accessible kidney donors, majority of 
patients should continue the hemodialysis (6,7).
Permanent hemodialysis catheter, due to larger diameter 
and flow, is an applicable method for vascular access in 
CKD patients (8). These catheters are concealed without 
restriction in physical activity and additional care by 
patients is not required (9). However, some adverse effects 
may be seen such as bleeding, hemothorax, pneumothorax, 
tamponade, and arrhythmia. Late side effects such as 
venous thrombosis, functional impairment, and infection 
may be seen (10,11).
Permicath is used in the maturation period of AVF to 
perform hemodialysis because non-tunneled central 
catheters may not be used up to four weeks due to the 
side effects such as infection and thrombosis (12,13). 
Hemodialysis is required due to lack of sufficient donors 
for kidney transplantation (14). Better hemodialysis 
methods with higher quality would result in increased 
quality of life. Also, good vascular access would increase 
the efficiency of treatment, quality of life, and the 
treatment course. In addition, it decreases the hospital 
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Abstract
Objective: Chronic kidney disease (CKD) is a complicated kidney defect causing permanent 
failure in renal function in progressive stages. Hemodialysis is the most accepted treatment 
to maintain body’s fluid/electrolyte homeostasis at the terminal stages of the disease. 
Permanent hemodialysis catheter (permicath) may be inserted blindly or by fluoroscopic 
guidance. This study aimed to compare the early function and complications between 
fluoroscopic guidance and blindly insertion of permanent hemodialysis catheter. 
Methods: This prospective randomized clinical trial was undertaken in the emergency 
department of Modarres hospital in Tehran, Iran during 2014 and 2015. Patients who 
needed catheter due to renal failure entered the study. Patients who needed emergency 
dialysis and those who could not wait for permicath were excluded. Patients were randomly 
assigned into 2 groups, under fluoroscopic guidance and blindly catheter insertion. Data 
were collected using a questionnaire and a checklist related to function (after 24 hours 
and 1 month), a need to exchange the catheter and the early adverse effects such as 
pneumothorax, hemothorax, and vascular injury.
Results: A total of 101 patients were enrolled in this trial. Early dysfunction (blind group = 
5), a need for catheter exchange (blind group = 2), pneumothorax (blind group = 2), 
vascular injury (blind group = 1) were recorded but the difference between the two groups 
was not statistically significant (P > 0.05).
Conclusion: We did not observe a significant difference between the placement of 
permicath by fluoroscopic or blind method. However, more studies with larger groups are 
recommended. 
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stay and mortality rate (15-17). 
Methods
In this prospective randomized clinical trial, 101 patients 
who visited the emergency department of Modarres 
hospital in Tehran during 2014 and 2015 and needed 
catheter because of renal failure were invited in the 
study as they met the inclusion criteria for permicath. 
Patients who needed emergency dialysis and could not 
wait for permicath were excluded. The inclusion criteria 
encompassed dialysis need for more than one month. 
Previous central catheterization was considered as the 
exclusion criteria. Early function and complications of 
tunneled dialysis catheterization by fluoroscopic guidance 
were compared with blind method. The procedures were 
done by one vascular surgeon.
Subjects were randomized in blind and fluoroscopic 
guidance groups. 
In the blind group after usual preparation, the patient 
was positioned in Trendelenburg with mild extension and 
rotation of the neck away from the side of internal jugular 
insertion. 
In the blind approach after local anesthesia, the puncture 
needle was inserted following ultrasound, between the 
medial and lateral heads of the sternocleidomastoid muscle 
and lateral to the carotid artery with 45 degrees directed to 
ipsilatral nipple. In the modified Seldinger technique after 
blood flushback, quidewire advanced through the needle 
and needle was removed. A small incision (#11 blade) 
was made at the guidewire skin enterance and extended 
to about 5 mm. The exit site marked on the chest wall 
was also incised about 5 mm. The subcutaneous tunneler 
was inserted into the chest incision and passed above 
the clavicle into the neck wound and catheter was pulled 
into the neck wound. The tract into the internal jugular 
vein was dilated over the guidewire, and the introducer 
sheath was inserted. Through this sheath catheter passed 
into centeral vein approximate supra vena caval and 
right atrium junction. Two lines were aspirated for more 
confidence and then were filled with serum-heparin. 
In the other group, fluoroscopic guide was used to see 
proper situation of wire and check the exact position and 
kinking of the catheter.
The early dysfunction and complications were seen 
during catheterization up to 24 hours after it and 
included the need to exchange the catheter because of 
malfunction, hemothorax, pneumothorax, vascular 
injury, and thoracotomy. Hemothorax and pneumothorax 
were assessed by chest radiography. One month later, all 
patients were again assessed for catheter malfunction and 
thrombosis of catheter 
SPSS software version 22 was used to perform the statistical 
analyses. Chi-square, student t test, and Fisher exact test 
were used and were considered statistically significant at P 
values less than 0.05.
Results
Totally, 101 patients were included in our trial in which in 
51 patients permicath catheter was inserted blindly and in 
50 patients it was inserted under fluoroscopic guidance. 
We did not observe a statistically significant difference 
regarding age between the two groups (P = 0.25) (Table 
1). Diabetes and hypertension were the most common 
underling diseases with 20.6% and 19.8% incidences 
respectively. Diabetes plus hypertension have been seen 
in 19.6% patients. 6.5% of patients had no underlying 
disease (Table 2). Function status at the first 24 hours 
was 98.1% and 100% in blind group and fluoroscopic 
group respectively (P = 0.98). Function status in the first 
month in the blind group was 90.2% and it was 98% 
in fluoroscopic group (P = 0.31). Function was better 
in fluoroscopic guidance group without a statistically 
significant difference (P > 0.05). The need to exchange was 
more in blind group but we did not observe a significant 
difference (P > 0.05). Complication rate was 5.8% in 
the blind group but without any complication rate in 
fluoroscopic guidance group. Despite this difference, 
there was not a statistically significant difference between 
the two groups (Table 3). 
Discussion
End-stage renal disease (ESRD) is the final stage of kidney 
disease requiring dialysis to prevent uremia. Nowadays the 
Table 1. Comparison of age between the two groups
Age
Mean SD Minimum Maximum P value
Blind (n=51) 58.7 2.2 23 92
0.25Fluoroscopy (n=50) 55 2.3 13 89
Total (n=101) 56.9 1.6 13 92
SD: standard deviation.                                    
Table 2. Frequency of disease
Disease No. %
Diabetes mellitus 22 20.6
Hypertension 20 19.8
Diabetes mellitus plus hypertension 21 19.6
Hypertension plus others 8 7.5
Diabetes mellitus plus others 1 0.9
Diabetes mellitus plus hypertension plus others 4 7.3
Others 18 17.8
Without Disease 7 6.5
Total 101 100
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hemodialysis is an active and the treatment situations are 
altered at each session and appropriate dialysis would result 
in decreased side effects and better quality of treatment 
(2,3). In cases needing urgent dialysis, the transient non-
tunneled catheters are good options for vascular access 
during hemodialysis (18,19). For long-term cases, the 
grafts and fistulas are more optimal. During maturation 
of arteriovenous fistula or in hypotensive patients, 
permanent catheters are good options. The patient’s 
situation may affect the used method. Transient methods 
are used in 7% which then are replaced with permanent 
methods (20,21). The complications of vascular access are 
causes of admission in 16% to 25% of cases (22). Some 
complications can be fatal or with morbidity (23,24)
We matched the age and background disease between the 
groups to reduce the confounding effects. Our results for 
this matter were similar to other studies (25,26). We found 
that function, side effects, and the need to exchange were 
similar between the two groups. The permanent catheter 
may be used if arteriovenous grafts and fistula are not 
appropriate. Previous studies have reported that early side 
effects are related to patient’s age and the experience of 
surgeon. In this regard, age was matched in our study and 
the procedures were done by one surgeon.
Conclusion
We postulate that there is no significant difference 
between the placement of catheter by fluoroscope and 
blind method. Although the early function and side effects 
in our study were the same between the two groups, but 
we did not observe long term function and complications 
such as thrombosis that can be due to inappropriate 
position of catheter. In addition, although there is no 
statically difference between two methods in early 
complications but even one side effect such as vascular 
injury may be disaster and we recommend to insertion 
of permanent catheter under fluoroscopic guidance. 
However, further studies in this area with larger sample 
size are also recommended.
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